Clinical trials and observational studies have shown that increased AGE and RAGE levels in patients with cardiovascular disease are associated with worse prognosis [9,10], and that post-AMI patients with increased plasma fluorescent AGE levels are at higher risk of developing heart failure (HF) [11]. Here, AGER is linked to cardiovascular disorder.